Monti DA, Zabrecky G, Kremens D, Liang TW, Wintering NA, Cai J, et al
El factor limitante del GLP-1 nativo radica en que es rpidamente metabolizado (en 2-3 minutos) por la accin del enzima dipeptidilpeptidasa-4, lo que impide su utilizacin teraputica(5)
Trimethylamine oxide induces pyroptosis of vascular endothelial cells through ALDH2/ROS/NLRP3/GSDMD pathway
Future perspectives Over the years, research has made significant progress in elucidating the mechanism of iron overload and the management of associated disorders in -thalassemia
4,5 Orforglipron and retatrutide from Eli Lilly exemplify the next generation of metabolic therapies: oral formulations that promise improved adherence, triple-hormone mechanisms that deliver superior weight loss and expanded therapeutic applications spanning from brain health to renal disease, Clarivate researchers noted
Individual health history can make one option more appropriate, less appropriate, or unsuitable